Lingjiao Wu

3.1k citations
31 papers · 608 indexed · h-index 12
Topics
Antibiotic Resistance in Bacteria (5 papers)MicroRNA in disease regulation (3 papers)Cancer-related molecular mechanisms research (3 papers)

In The Last Decade

Lingjiao Wu

27 papers receiving 606 citations

Peers

Lingjiao Wu
Comparison fields: 5 of 90
  • Molecular Biology 414
  • Cancer Research 237
  • Epidemiology 67
  • Infectious Diseases 62
  • Surgery 41
Replace Ruibing Yang with:
Ruibing Yang China
Vindhya Palagani Germany
Benjamin W. Casterline United States
Lan Peng United States
Su Jin Park South Korea
Nicole Paland Israel
Xingmei Liu China
Tapas Patra United States
Rodrigo Aguilera Olvera United States
Lingjiao Wu relative to Ruibing Yang China Ruibing Yang's profile →
Citations per field
00.5×4.6×
Ruibing Yang · 1×
Citations per year

Countries citing papers authored by Lingjiao Wu

Since Specialization
Citations

This map shows the geographic impact of Lingjiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjiao Wu more than expected).

Fields of papers citing papers by Lingjiao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjiao Wu. The network helps show where Lingjiao Wu may publish in the future.

Co-authorship network of co-authors of Lingjiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjiao Wu. A scholar is included among the top collaborators of Lingjiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjiao Wu. Lingjiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 4
6 9
7 32
8 2
9 39
10 8
11 29
12 24
13 93
14 30
15 47
16 6
17 12
18 5
19
[Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
13
20 28

About Lingjiao Wu

Lingjiao Wu is a scholar working on Molecular Medicine, Endocrinology and Cancer Research, having authored 31 papers that have together received 608 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (237 citations), Molecular Medicine (31 citations) and Molecular Biology (414 citations). Lingjiao Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fusheng Wu, Qiangfeng Wang, Zeran Yang, Xiuming Zhu, Rong Yang, Jie Xu, Jian Yao, Beiwen Zheng, Shusen Zheng and Guohong Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026